Skip to main content

Table 1 Patients’ characteristics

From: The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

 

Total

FSS (N%)

Radical surgery (N%)

Total

92

54 (58.7)

38 (41.3)

FIGO stage

 IA

35 (38)

31 (57.4)

4 (10.5)

 IB

9 (9.8)

3 (5.6)

6 (15.8)

 IC

18 (19.6)

8 (14.8)

10 (26.3)

 II

8 (8.7)

1 (1.9)

7 (18.4))

 III

22 (23.9)

11 (20.4)

11 (28.9)

Diameter

 < 10 cm

50 (54.3)

27 (50.0)

23 (60.5)

 ≥ 10 cm

42 (45.7)

27 (50.0)

15 (39.5)

Histology

 Serous

46 (50)

26 (48.1)

20 (52.6)

 Mucinous

38 (41.3)

25 (46.3)

13 (34.2)

 Endometrioid

7 (7.6)

2 (3.7)

5 (13.2)

 Serous and mucinous

1 (1.1)

1 (1.9)

0 (0)

Lesion lateral

 Left

44 (47.8)

26 (48.1)

18 (47.4)

 Right

29 (31.5)

17 (31.5)

12 (31.6)

 Bilateral

19 (20.7)

11 (20.4)

8 (21.1)

Rupture

 Yes

17 (18.5)

10 (18.5)

7 (18.4)

 No

75 (81.5)

44 (81.5)

31 (81.6)

Micropapillary

 Yes

16 (17.4)

11 (20.4)

5 (13.2)

 No

76 (82.6)

43 (79.6)

33 (86.8)

Microinvasion

 Yes

7 (7.6)

5 (9.3)

2 (5.3)

 No

85 (92.4)

49 (90.7)

36 (94.7)

Invasive implants

 Yes

4 (4.3)

2 (3.7)

2 (5.3)

 No

88 (95.7)

52 (96.3)

36 (94.7)

Pelvic lymph node

 Positive

10 (10.9)

6 (11.1)

4 (10.5)

 Negative

82 (89.1)

48 (88.9)

34 (89.5)

Para-aortic lymph node

 Positive

3 (3.3)

2 (3.7)

1 (2.6)

 Negative

89 (96.7)

52 (96.3)

37 (97.4)

Lymphadenectomy

 Yes

55 (59.8)

26 (48.1)

29 (76.3)

 No

37 (40.2)

28 (51.9)

9 (23.7)

Surgery approach

 Laparoscopy

7 (7.6)

5 (9.3)

2 (5.3)

 Laparotomy

85 (92.4)

49 (90.7)

36 (94.7)

Adjuvant chemotherapy

 Yes

10 (10.9)

4 (7.4)

6 (15.8)

 No

82 (89.1)

50 (92.6)

32 (84.2)

Staging surgery

 Yes

87 (94.6)

51 (94.4)

36 (94.7)

 No

5 (5.4)

3 (5.6)

2 (5.3)

Appendectomy

 Yes

8 (8.7)

5 (9.3)

3 (7.9)

 No

84 (91.3)

49 (90.7)

35 (92.1)

Recurrence

 Yes

22 (23.9)

19 (35.2)

3 (7.9)

 No

70 (76.1)

35 (64.8)

35 (92.1)

Death

0

0

0